- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05954585
Family Navigator Intervention
January 22, 2024 updated by: Mary Kathryn Cancilliere, Rhode Island Hospital
The Development of a Family Navigator Intervention and Prevention Protocol to Reduce Risk of Suicide and Self-injurious Behavior for Youth Aged 10 to 14 Years
This study will develop and examine the feasibility and acceptability of a family navigator protocol while leveraging digital health communication.
It will employ an ecological model within a socio-cultural theoretic framework of mental health service disparities and barriers to treatment.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study is to develop and pilot a Family Navigator intervention with technology-enhanced information sharing for families with youth (80 youth-caregiver dyads) who were discharged from the emergency after an admission for SSIB.
This novel intervention aims to reduce suicidal and non-suicidal self-injurious behavior risk and prevalence rates by way of increasing attendance to community-based mental health services for youth aged 10 to 14.
Study Type
Interventional
Enrollment (Estimated)
160
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Mary Kathryn Cancilliere, PhD
- Phone Number: 401-444-7443
- Email: Marykathryn.cancilliere@lifespan.org
Study Contact Backup
- Name: Julie Bromberg, MPH
- Phone Number: 401-444-8403
- Email: JBromberg@Lifespan.org
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02903
- Recruiting
- Rhode Island Hospital
-
Contact:
- Mary Kathryn Cancilliere, PhD
- Phone Number: 401-444-7443
-
Principal Investigator:
- Mary Kathryn Cancilliere, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- youth 10 to 14 years old living at home with legal guardian/caregiver
Exclusion Criteria:
- presentation including psychosis, sexual assault, or child abuse,
- are in police or child protective services' custody,
- are unable to assent due to severity of illness or developmental disabilities, >cannot communicate in English or Spanish, or
- if no caregiver or legal guardian is able to provide consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Treatment as usual
Emergency department treatment as usual
|
Emergency department treatment as usual
|
Experimental: Family Navigator
Follow provision provided by a Family Navigator for the length of the treatment or until youth attends community-based mental health care
|
Family Navigator will speak with families about individual and systemic issues for linkage to mental health care biweekly for 3 months or until the youth's first mental health appt has been attended, whichever comes first.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mental Health Services
Time Frame: 6 months
|
adapted CASA
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Suicidal ideation
Time Frame: 6 months
|
Suicidal Ideation Questionnaire
|
6 months
|
Suicidal behavior
Time Frame: 6 months
|
Suicidal Ideation Questionnaire
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Michael Mello, MD, PI COBRE
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 2, 2023
Primary Completion (Estimated)
May 14, 2025
Study Completion (Estimated)
May 14, 2025
Study Registration Dates
First Submitted
July 12, 2023
First Submitted That Met QC Criteria
July 12, 2023
First Posted (Actual)
July 20, 2023
Study Record Updates
Last Update Posted (Estimated)
January 24, 2024
Last Update Submitted That Met QC Criteria
January 22, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- COBRE.RIH100
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Treatment as Usual
-
University of HoustonTexas Women's UniversityRecruitingTreatment as Usual | MISC InterventionUnited States
-
Amrit SinhaNational Health Service, United KingdomUnknownTreatment as Usual | Psychological InterventionUnited Kingdom
-
Nottinghamshire Healthcare NHS TrustUniversity of Nottingham; University of Southampton; University of Leicester; Institute...TerminatedTreatment as Usual | Employment, SupportedUnited Kingdom
-
New York UniversityPlanned Parenthood Federation of AmericaCompletedTreatment as Usual | New Behavioral ProtocolUnited States
-
Tampere UniversityCompletedTreatment as Usual | Narrative Exposure TherapyFinland
-
University Hospital HeidelbergInnovationsfonds des Gemeinsamen Bundesausschusses, GermanyCompletedPatient Decision Aid | Treatment As UsualGermany
-
Babes-Bolyai UniversityActive, not recruitingREThink Game | Treatment-as-usualRomania
-
Florida International UniversityCompletedBehavior Therapy + MI Intervention (Supporting Teens' Academic Needs Daily) | Treatment as Usual
-
Indiana UniversityUniversity of South Florida; National Institute on Minority Health and Health... and other collaboratorsCompletedModified DECIDE Intervention | Treatment as Usual Care GroupUnited States
-
University of North Carolina, Chapel HillThe Foundation of Hope for Research and Treatment of Mental IllnessTerminatedTreatment as Usual | Partner Assisted Interpersonal PsychotherapyUnited States
Clinical Trials on Family Navigator
-
Boston Medical CenterCompletedAutistic DisorderUnited States
-
Children's Hospital Medical Center, CincinnatiOffice of Head StartCompleted
-
Florida State UniversityNational Institute of Mental Health (NIMH); Emory University; Weill Medical College... and other collaboratorsCompletedAutism Spectrum DisorderUnited States
-
Washington State UniversityNational Institute of Mental Health (NIMH)Recruiting
-
University of Maryland, BaltimoreCompleted
-
Vanderbilt UniversityRecruitingAutism Spectrum Disorder | Mental Health ServicesUnited States
-
Children's Hospital of PhiladelphiaNational Institute on Minority Health and Health Disparities (NIMHD)Active, not recruitingDevelopment Delay | Development, ChildUnited States
-
Stanford UniversityTerminatedGenital Neoplasms, Female | Breast Cancer | Gynecologic CancersUnited States
-
Karolinska InstitutetRegion Stockholm; Forte; Stiftelsen Frimurarna BarnhusetActive, not recruitingDepression | Stress, Psychological | Intellectual Disability | Anxiety | Neurodevelopmental Disorders | Traumatic Brain Injury | Autism Spectrum Disorder | Parents | Attention Deficit Hyperactivity Disorder | Physical DisabilitySweden
-
University Medical Centre LjubljanaKarolinska Institutet; Schneider Children's Medical Center, IsraelCompletedHypoglycemia | Diabetes Mellitus, Type 1Sweden, Israel, Slovenia